Trade Summary

1 week ago, Selecky Christobel, serving as Dir at ImmunityBio, Inc. (IBRX), sold 159,478 shares at $9.02 per share, for a total transaction value of $1,439,065.68.

This sale represents a 100.00% decrease in Selecky Christobel's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, July 1, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, July 7, 2026 (accepted Jul 6, 8:25 PM ET), 6 days after the trade was made.

ImmunityBio, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.